Diclofenac - Assertio Therapeutics
Alternative Names: Lynxorb™; ProSorb-D™; XP 21L; ZipsorLatest Information Update: 17 Dec 2021
Price :
$50 *
At a glance
- Originator AAIPharma
- Developer Assertio Therapeutics
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acute pain